Synapse - Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy

Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy Meeting Abstract

Authors:	Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; Castillo Flores, N.; Politikos, I.; Scordo, M.; Shah, G. L.; Cho, C.; Lin, R. J.; Maloy, M. A.; Devlin, S. M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M.; Giralt, S. A.; Smith, M.
Abstract Title:	Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
Meeting Title:	Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	26
Issue:	3 Suppl.
Meeting Dates:	2020 Feb 19-23
Meeting Location:	Orlando, FL
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2020-03-01
Start Page:	S97
End Page:	S98
Language:	English
ACCESSION:	WOS:000516887900131
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2019.12.598
Notes:	Meeting Abstract: 130 -- Source: Wos